Research assistance

We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 

Matching geography

Reports matching your search in:
 
 

Join Alert Me now!

Receive bi-weekly email alerts on new market research

Sign up today!
 

Biotechnology: market research reports

1594

The biotechnology industry encompasses the spectrum of life science-based research companies developing products and services for a wide variety of industries and applications. The industry holds the promise of transformative technologies from agriculture to materials science to environmental science to medicine. In agriculture, biotech products enhance crop yield, advance the nutritional value and quality of crops and livestock, and improve the efficacy and safety of pesticides.
In material science, biotechnology is adding to advances in polymer science and the coatings industry. In environmental science, biotech has contributed innovative solutions to environmental clean-up and waste management.

The biggest direct impact of biotechnology, and the biggest market for its products, is in medicine and healthcare. The biotechnology industry is, in many ways, becoming the research and development engine of the pharmaceutical industry. The tools and techniques of genetic analysis and manipulation are at the heart of the drug discovery process, and many of the largest biotech firms have been transformed over the past decade into pharmaceutical and biopharmaceutical giants.

The biotechnology category covers the companies, technologies, tools, and applications of the advanced life science sector. Included are reports on research methods and equipment such as liquid chromatography, mass spectroscopy, genetic sequencing, gene expression, etc. There are also reports on the business of biotechnology, mergers & acquisitions, and funding. Insofar as the sector intersects with the pharmaceutical industry, there are also reports on product pipelines, strategies for drug development and manufacturing such as biogenerics, biosimilars and biomanufacturing. Reports cover so-called green- and white-biotech sectors as well.

RSS Feeds

Biotechnology market research reports and industry analysis

< prev 1  2  3  4  5  6  7  8  9  10  next >
RTI Biologics, Inc. (RTIX) - Product Pipeline Analysis
11/28/2012 | published by: GlobalData
... produces Allograft tissue and Xenograft tissue utilizing proprietary BIOCLEANSE and TUTOPLAST sterilization processes. It has manufacturing facilities in Alachua, Florida and Neunkirchen, Germany. RTI has non-exclusive relationships with some of the leading pharmaceutical companies to ...  |  more...
$750.00
IntegraGen S.A (ALINT) - Product Pipeline Analysis
11/28/2012 | published by: GlobalData
... prevention and proactive management of complex debilitating diseases and is focused on the development and delivery of genetic tests for complex diseases. It develops molecular markers for central nervous system and metabolic diseases. The company ...  |  more...
$750.00
Tigran Technologies AB (TIGR) - Product Pipeline Analysis
11/28/2012 | published by: GlobalData
... Tigran Technologies’s products include Tigran PTG, a porous titanium granule for the regeneration of bones; and Tigran Brush No. 1, a rotating titanium brush for mechanical debridement around implants in connection with peri-implantitis treatment. The ...  |  more...
$750.00
OncoVista Innovative Therapies, Inc. (OVIT) - Product Pipeline Analysis
11/28/2012 | published by: GlobalData
... and L-Nucleoside Conjugates (OVI-117). OVI-123 is in its Phase I/II clinical development and OVI-117 is in pre-clinical development stage. The company's extensive in-house pre-clinical and clinical expertise has provided it with a broad pipeline of ...  |  more...
$750.00
Axial Biotech, Inc. - Product Pipeline Analysis
11/28/2012 | published by: GlobalData
... the genetic foundation of spinal disorders. Axial Biotech’s developments include the discovery and development in the areas of degenerative disc disease, scoliscore ais prognostic test and pharmacogenomic product development. The company also provides medical educational ...  |  more...
$750.00
MabCure Inc. (MBCI) - Product Pipeline Analysis
11/28/2012 | published by: GlobalData
... prostate and ovarian cancers at an early stage. The company also develops new technologies for the early detection of cancer as well antibodies and drugs that attacks on cancer cells. The company uses its cancer-specific ...  |  more...
$750.00
Nanobiotix - Product Pipeline Analysis
11/28/2012 | published by: GlobalData
... network with radiotherapy improving the tumor control using the existing standard radiation equipment available world-wide. Nanobiotix’s nanoXray also treats pathologies, such as glioblastoma multiform, head and neck cancer, lung cancer, and brain metastases. It is ...  |  more...
$750.00
ECI Biotech Inc. - Product Pipeline Analysis
11/28/2012 | published by: GlobalData
... diagnostics products for rapid infection determination. The company’s infection sensor diagnostics can be incorporated into any medical device or consumer product and will ultimately transform the way pathogens are detected in wound care, women's health, ...  |  more...
$750.00
ImmusanT, Inc. - Product Pipeline Analysis
11/28/2012 | published by: GlobalData
... the damage of small intestine lining and prevents it from absorbing parts of food that are necessary for staying healthy. The company is currently developing peptide-based therapeutic vaccine, Nexvax2, for treating, preventing, and diagnosing celiac ...  |  more...
$750.00
Global Quantitative and dPCR Instrumentation and Consumables Purchasing Trends
11/26/2012 | published by: Frost & Sullivan
... technology. The research strives to compare differences of current and future use between qPCR and dPCR; identify dPCR and dPCR technology brand use and future use trends; evaluate currently used qPCR and dPCR technology brands; ...  |  more...
$10,000.00
Analysis of the Global Animal Health Market, and Leading Suppliers' Marketing Tactics and Technological Know-How
11/20/2012 | published by: Venture Planning Group
... on the animal health industry during the next five years, including discussion of such issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue ...  |  more...
$3,450.00
Genus plc (GNS) - Financial and Strategic SWOT Analysis Review
11/20/2012 | published by: GlobalData
... primary activities of the company include supply of dairy and beef cattle semen under ABS trademark; supply of pigs and their semen under PIC trade mark; and value added and technical support services. The key ...  |  more...
$125.00
Top 100 Proteomics (Global)
11/19/2012 | published by: Plimsoll Publishing Ltd.
... industry averages.Using the most up-to-date financial information available, the two-page per company analysis provides detailed financial analysis for each organisation. The following are some of the key findings of this new report: 20 of the ...  |  more...
$1,500.00
White Paper: The Scourge of Cancer (Incidence by Country, Mechanisms, Growth Factors)
11/19/2012 | published by: Kalorama Information
... of yearly cancer cases by country and explains the mechanism of cancer growth. For more detailed information, including market forecasts for each major type of anti-cancer therapy, customers will want to purcahse the market full ...  |  more...
Top 300 Starch & Starch Products (China)
11/19/2012 | published by: Plimsoll Publishing Ltd.
... and compared to industry averages.Using the most up-to-date financial information available, the two-page per company analysis provides detailed financial analysis for each organisation. The following are some of the key findings of this new report: ...  |  more...
$1,000.00
Top 250 Biotechnology (Nordic)
11/19/2012 | published by: Plimsoll Publishing Ltd.
... industry averages.Using the most up-to-date financial information available, the two-page per company analysis provides detailed financial analysis for each organisation. The following are some of the key findings of this new report: 60 of the ...  |  more...
$1,050.00
A comprehensive study of the UK Medical Research market in 2010, rating & valuing each of the 107 companies that operate in today's market
11/19/2012 | published by: Plimsoll Publishing Ltd.
... Identify under performing companies for acquisition Seek out successful companies to partner or do business with Understand the key movers and shakers in today’s market Each company receives the following unique features: A 5 year ...  |  more...
$350.00
Top 390 Biotechnology (Pharmaceuticals) (Global)
11/19/2012 | published by: Plimsoll Publishing Ltd.
... to industry averages.Using the most up-to-date financial information available, the two-page per company analysis provides detailed financial analysis for each organisation. The following are some of the key findings of this new report: 197 of ...  |  more...
$1,500.00
Lightlake Therapeutics Inc. (LLTP) - Financial and Strategic SWOT Analysis Review
11/15/2012 | published by: GlobalData
... Nervosa. The company operates through an international team of research scientists, pharmacologists and doctors. Lightlake Therapeutics focuses on the removal of opioidergic addictions, drugs safety and efficacy through clinical trials in the US, Finland, the ...  |  more...
$125.00
Lonza Group Ltd (LONN) - Financial and Strategic SWOT Analysis Review
11/15/2012 | published by: GlobalData
... in the biotechnology, pharmaceutical, academic, and government research industries to manufacturers of health and consumer products, distributors, formulators and service companies. The company’s major markets include bioresearch, nutrition, pharma and biotech, microbial control, agriculture, materials ...  |  more...
$125.00
Starches and Starch Products in USA: ISIC 1532
11/13/2012 | published by: Euromonitor International
... level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - ...  |  more...
$600.00
Drug Discovery and Development Market in Asia - Partnerships Between MNCs and Asian Academic Institutions and Healthcare Research Organizations are Driving R&D Innovation
11/9/2012 | published by: GBI Research
... research, “Drug Discovery and Development Market in Asia - Partnerships Between MNCs and Asian Academic Institutions and Healthcare Research Organizations are Driving R&D Innovation”. The report provides key data, information and analysis of the major ...  |  more...
$3,500.00
Biomarkers in Drug Discovery - Integration in Early Stage Promotes Use of Companion Diagnostics to Optimize Therapeutic Outcomes
11/9/2012 | published by: GBI Research
... Companion Diagnostics to Optimize Therapeutic Outcomes” provides information and analysis on the major trends and issues affecting biomarkers in the drug discovery process. The report describes the history of biomarkers and their role in fulfilling ...  |  more...
$3,500.00
Global Kinase Inhibitors Market 2011-2015
11/9/2012 | published by: Infiniti Research Limited
... prevalence of disease. The Global Kinase Inhibitor market has also been witnessing the trend of an increase in the number of mergers and acquisitions. However, patent expiration of kinase inhibitors could pose a challenge to ...  |  more...
$1,500.00
Cell Culture - Rising Demand for Biologics and Growing Visibility of Approval Pathway for Biosimilars will Create Growth Opportunities
11/9/2012 | published by: GBI Research
... Rising Demand for Biologics and Growing Visibility of Approval Pathway for Biosimilars will Create Growth Opportunities”, which provides in-depth analysis on the processes, drivers and barriers of the cell culture market. The report analyzes the ...  |  more...
$3,500.00
< prev 1  2  3  4  5  6  7  8  9  10  next >